	PEOPLE	CENTERS	COMMUNITIES	RESEARCH STORIES

ASSESSING DRUG COMBINATIONS FOR THE TREATMENT OF PROSTATE CANCER

ASSESSING DRUG COMBINATIONS FOR THE TREATMENT OF PROSTATE CANCER

PI: Marc Cox

Sponsor: NIH - NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH TEXAS SOUTHERN UNIVERSITY

Biological Sciences

Amount awarded: $10,000

This project validates whether MJC13 and docetaxel or GMC1 and docetaxel act synergistically against prostate cancer.

Posting date: Fri, 02/26/2021

Award start date: Mon, 03/01/2021

Award end date: Mon, 02/28/2022

© 2013 The University of Texas at El Paso | Terms Of Use | Privacy Statement | Questions or Comments about this site? Click here

Some of the content on this web site includes information taken from UTEP's Faculty Success (formerly Digital Measures) and Marketing and Communications.
This material is based upon work supported in part by the Research & Innovation and the National Science Foundation under Grant No. DUE-0963648 and CREST Grant No. HRD-1242122. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation (NSF).